Rigel Pharmaceuticals
RIGL
#6528
Rank
NZ$1.29 B
Marketcap
NZ$71.19
Share price
-8.22%
Change (1 day)
143.80%
Change (1 year)

Market capitalization of Rigel Pharmaceuticals (RIGL)

Market cap: NZ$1.29 Billion

As of January 2026 Rigel Pharmaceuticals has a market cap of NZ$1.29 Billion. This makes Rigel Pharmaceuticals the world's 6528th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Rigel Pharmaceuticals from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.29 B-6.31%
2025NZ$1.37 B167.65%
2024NZ$0.51 B28.9%
2023NZ$0.39 B-2.09%
2022NZ$0.40 B-38.45%
2021NZ$0.66 B-19.06%
2020NZ$0.81 B53.56%
2019NZ$0.53 B-6.88%
2018NZ$0.57 B-28.38%
2017NZ$0.80 B135.43%
2016NZ$0.33 B-15.21%
2015NZ$0.40 B57.17%
2014NZ$0.25 B-15.97%
2013NZ$0.30 B-55.91%
2012NZ$0.68 B-4.4%
2011NZ$0.72 B41.17%
2010NZ$0.51 B-25%
2009NZ$0.68 B34.89%
2008NZ$0.50 B-51.52%
2007NZ$1.04 B145.18%
2006NZ$0.42 B39.79%
2005NZ$0.30 B-54.89%
2004NZ$0.67 B53.63%
2003NZ$0.43 B355.53%
2002NZ$96.14 M-77.24%
2001NZ$0.42 B-49.12%
2000NZ$0.83 B

End of Day market cap according to different sources

On Jan 10th, 2026 the market cap of Rigel Pharmaceuticals was reported to be:

NZ$1.29 Billion
by Nasdaq info icon info icon
NZ$1.29 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ChemoCentryx
CCXI
NZ$6.51 B 404.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.25 B-79.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$511.57 B 39,488.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
NZ$306.10 B 23,587.89%๐Ÿ‡บ๐Ÿ‡ธ USA